Experience the FFRD symposium on “Beta Cell” as if you were there! This event took place during last year’s SFD congress in Toulouse, highlighting fundamental research and the French speaking scientific community…

🏆 Romano REGAZZI (Lausanne): recipient in 2013
🏆 Raphael SCHARFMANN (Paris): recipient in 2017
🏆 Miriam CNOP (Bruxelles): recipient in 2019

Moderated by the Presidency, the President of the Scientific Council and the founders of the FFRD.

 


🎤 MODERATORS 🎤

 

  • Hélène HANAIRE, President of the FFRD (2021-2024)
  • André SCHEEN, President of the Scientific Council of the FFRD
  • Jean GIRARD, Vice-President of the Scientific Council of the FFRD
  • Michel MARRE, former President and founder of the FFRD
  • Bernard BAUDUCEAU, former Treasurer and founder of the FFRD

 

 

 

 

 

🏆 Romano REGAZZI 🏆

  • from the University of Lausanne (Switzerland), laureate of a fundamental research grant, in 2013, for his project on the “role of long non-coding RNAs and circular RNAs in the determination of beta cell phenotype and the development of diabetes”.

 

 

 

 

🏆 Raphael SCHARFMANN 🏆

  • from INSERM Paris (France), laureate of a fundamental research grant, in 2017, for his project on “a reconstructing of the human fetal pancreas”.

 

 

 

 

🏆 Miriam CNOP 🏆

  • from the University Libre de Bruxelles (Belgium), laureate of a fundamental research grant, in 2019, for her project on “modeling endoplasmic reticulum stress and diabetes using human beta cells derived from stem cells”.

 

 

 

📢 Next FFRD Symposium during the SFD congress in Paris 📢

 

📆 Wednesday 2nd April 2025! 🕙 from 10:30 AM to 12:00PM

📍 Palais des Congrès in Paris (Room Ternes)

🧬 FFRD Symposium on the MICROBIOTA: from the pathophysiology to therapeutic interventions:

  • Rémy BURCELIN (Toulouse): Microbiota and intestinal mucosal immune system in patients with abdominal obesity and type 2 diabetes,
  • François PATTOU (Lille): The role of intestine in type 2 diabetes remission after gastric by-pass surgery,
  • Hubert VIDAL (Lyon): PROBIODIAB: Probiotics as a new treatment for type 2 diabetes.

 

In the presence of the moderaors: Bruno VERGÈS, President of the FFRD and Hélène HANAIRE, former President ; André SCHEEN, President and Jean GIRARD, Vice-President of the Scientific Council of the FFRD.

The FFRD is committed to all stages of the Francophone research… For the advancement of diabetes research!